Kirk; Allan D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kirk; Allan D..The latest application filed is for "use of machine learning models for prediction of clinical outcomes".

Company Profile

2.4.10

Kirk; Allan D. - Durham NC
Kirk; Allan D - Durham NC
Kirk; Allan D. - Atlanta GA
Kirk; Allan D. - Potomac MD
Kirk; Allan D. - Darnestown MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating costimulation blockade resistant rejection Grant 11,385,228 - Kirk , et al. July 12, 2	2022-07-12
Use Of Machine Learning Models For Prediction Of Clinical Outcomes App 20210327540 - Schobel; Seth A ; et al.	2021-10-21
Methods For Treating Costimulation Blockade Resistant Rejection App 20200072838 - Kirk; Allan D. ; et al.	2020-03-05
Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept Grant 10,488,413 - Kirk , et al. Nov	2019-11-26
Methods For Identifying Patients At Risk For Costimulation Blockade Resistant Rejection App 20170328903 - KIRK; Allan D ; et al.	2017-11-16
Methods For Identifying Patients At Risk For Costimulation Blockade Resistant Rejection App 20160153990 - KIRK; Allan D ; et al.	2016-06-02
Methods for determination of calcineurin activity and uses in predicting therapeutic outcomes Grant 8,546,095 - Tumlin , et al. October 1, 2	2013-10-01
Methods For Determination of Calcineurin Activity and Uses in Predicting Therapeutic Outcomes App 20100159475 - TUMLIN; JAMES ; et al.	2010-06-24
Treatment of Inappropriate Immune Responses App 20080124343 - Xu; He ; et al.	2008-05-29
Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection App 20070244053 - Kirk; Allan D. ; et al.	2007-10-18
Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof App 20070212701 - O'Toole; Margot M. ; et al.	2007-09-13
N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response App 20060171944 - Lekstrom-Himes; Julie A. ; et al.	2006-08-03
Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection App 20020119150 - Kirk, Allan D. ; et al.	2002-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.